BioCryst Pharmaceuticals | BCRX - أصول متداولة

سعر السهم
9.78
التغيير اليومي
0.08 0.82%
شهريا
28.52%
سنويا
21.49%
Q1 التوقعات
9.41




أصول متداولة تغيير تاريخ
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
Chugai Pharma JPY 1.74T 223.03B 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
DBV Technologies USD 88.88M 32.36M 2025-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novavax USD 978.28M 3.69M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12